首页> 外文会议>Brazilian Polymer Conference >Synthesis of Nanoparticles Loaded with Tamoxifen by in Situ Miniemulsion RAFT Polymerization
【24h】

Synthesis of Nanoparticles Loaded with Tamoxifen by in Situ Miniemulsion RAFT Polymerization

机译:用原位小乳液筏聚合合成用Tamoxifen负载的纳米颗粒

获取原文

摘要

Tamoxifen (TXF) is a drug used as a hormonal agent for treatment of breast cancer. Due to its low solubility/bioavailability, the effectiveness of TXF can be improved when the drug is combined with drug delivery systems (DDS). For this reason, the in situ incorporation of TXF in polymer particles produced through miniemulsion polymerizations is studied here. Reactions were performed through standard free radical (FR) and RAFT polymerizations, using methyl methacrylate (MMA) as monomer and 2,2’-azobisisobutironitrila (AIBN) as initiator. It is shown that TXF can be incorporated successfully into the final polymer particles through miniemulsion polymerizations and that the presence of TXF in the reaction medium does not affect significantly the reaction rates, the particle size distribution and the molar mass distribution of the final polymer, even when the monomer feed contains 10 wt% of drug. Therefore, it is shown that DDS containing TXF can be produced by in situ miniemulsion FR and RAFT MMA polymerizations.
机译:Tamoxifen(TXF)是一种用作治疗乳腺癌的激素剂的药物。由于其低溶解度/生物利用度,当药物与药物递送系统(DDS)结合时,可以改善TXF的有效性。因此,研究了通过微乳液聚合制备的聚合物颗粒中TXF的原位掺入。通过标准自由基(FR)和筏聚合,使用甲基丙烯酸甲酯(MMA)作为单体和2,2'-偶氮二茴香呋喃腈(AIBN)作为引发剂来进行反应。结果表明,TXF可以通过微乳液聚合成功掺入最终的聚合物颗粒中,并且在反应介质中的TXF的存在不会显着影响反应速率,粒度分布和最终聚合物的摩尔质量分布当单体进料含有10wt%的药物时。因此,显示含有TXF的DDS可以通过原位小乳液FR和筏MMA聚合来制备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号